Elevated incidence of sleep apnoea in acromegaly - Correlation to disease activity

Sleep and Breathing

Volumn 16, Issue 4, 2012, Pages 1247-1253

  Roemmler, J ^a   Gutt, B ^b   Fischer, R ^a   Vay, S ^a   Wiesmeth, A ^c   Bidlingmaier, M ^a   Schopohl, J ^a   Angstwurm, M ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b Klinikum Schwabing   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acromegaly; Disease activity; Disease duration; Sleep apnoea

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; GROWTH HORMONE; HEMOGLOBIN A1C; PEGVISOMANT; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADULT; AGED; APNEA; ARTICLE; BODY MASS; CENTRAL SLEEP APNEA SYNDROME; DIASTOLIC BLOOD PRESSURE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; PREVALENCE; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING; SYSTOLIC BLOOD PRESSURE; CROSS-SECTIONAL STUDY; GERMANY; INCIDENCE; MIDDLE AGED; RISK FACTOR; STATISTICS;

ACROMEGALY; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 84877122971     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-011-0641-7     Document Type: Article

References (31)

1. Series F, Cormier Y, La Forge J (1990) Influence of apnea type and sleep stage on nocturnal postapneic desaturation. Am Rev Respir Dis 141(6):1522-1526
2. Weitzenblum E, Krieger J, Apprill M, Vallee E, Ehrhart M, Ratomaharo J, Oswald M, Kurtz D (1988) Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 138(2):345-349
3. Bradley TD, Rutherford R, Grossman RF, Lue F, Zamel N, Moldofsky H, Phillipson EA (1985) Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 131(6):835-839
4. Wright AD, Hill DM, Lowy C, Fraser TR (1970) Mortality in acromegaly. Q J Med 39(153):1-16
5. Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102-152
6. Giustina A, Melmed S (2003) Acromegaly consensus: the next steps. J Clin Endocrinol Metab 88(4):1913-1914
7. Orme SM, McNally RJ, Cartwright RA, Belchetz PE (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 83(8):2730-2734
8. Rosenow F, Reuter S, Deuss U, Szelies B, Hilgers RD, Winkelmann W, Heiss WD (1996) Sleep apnoea in treated acromegaly: relative frequency and predisposing factors. Clin Endocrinol (Oxf) 45(5):563-569
9. Grunstein RR, Ho KY, Sullivan CE (1991) Sleep apnea in acromegaly. Ann Intern Med 115(7):527-532
10. Dostalova S, Sonka K, Smahel Z, Weiss V, Marek J, Horinek D (2001) Craniofacial abnormalities and their relevance for sleep apnoea syndrome aetiopathogenesis in acromegaly. Eur J Endocrinol 144(5):491-497
11. Hochban W, Ehlenz K, Conradt R, Brandenburg U (1999) Obstructive sleep apnoea in acromegaly: the role of craniofacial changes. Eur Respir J 14(1):196-202
12. Grunstein RR, Ho KY, Berthon-Jones M, Stewart D, Sullivan CE (1994) Central sleep apnea is associated with increased ventilatory response to carbon dioxide and hypersecretion of growth hormone in patients with acromegaly. Am J Respir Crit Care Med 150(2):496-502
13. Herrmann BL, Wessendorf TE, Ajaj W, Kahlke S, Teschler H, Mann K (2004) Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly. Eur J Endocrinol 151(3):309-315
14. Weiss V, Sonka K, Pretl M, Dostalova S, Klozar J, Rambousek P, Marek J, Haas T (2000) Prevalence of the sleep apnea syndrome in acromegaly population. J Endocrinol Invest 23(8):515-519
15. Hart TB, Radow SK, Blackard WG, Tucker HS, Cooper KR (1985) Sleep apnea in active acromegaly. Arch Intern Med 145(5):865-866
16. Davi MV, Dalle Carbonare L, Giustina A, Ferrari M, Frigo A, Lo Cascio V, Francia G (2008) Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. Eur J Endocrinol 159(5):533-540
17. Berg C, Wessendorf TE, Mortsch F, Forsting M, Teschler H, Weischer T, Mann K, Saller B, Herrmann BL (2009) Influence of disease control with pegvisomant on sleep apnoea and tongue volume in patients with active acromegaly. Eur J Endocrinol 161(6):829-835
18. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring systems for sleep stages of human subjects. Brain Information Service/Brain Research Institute, University of California Los Angeles, Los Angeles
19. Sze L, Schmid C, Bloch KE, Bernays R, Brandle M (2007) Effect of transsphenoidal surgery on sleep apnoea in acromegaly. Eur J Endocrinol 156(3):321-329
20. Ip MS, Tan KC, Peh WC, Lam KS (2001) Effect of Sandostatin LAR on sleep apnoea in acromegaly: correlation with computerized tomographic cephalometry and hormonal activity. Clin Endocrinol (Oxf) 55(4):477-483
21. Ezzat S, Forster MJ, Berchtold P, Redelmeier DA, Boerlin V, Harris AG (1994) Acromegaly. Clinical and biochemical features in 500 patients. Medicine (Baltimore) 73(5):233-240
22. Fatti LM, Scacchi M, Pincelli AI, Lavezzi E, Cavagnini F (2001) Prevalence and pathogenesis of sleep apnea and lung disease in acromegaly. Pituitary 4(4):259-262
23. van Haute FR, Taboada GF, Correa LL, Lima GA, Fontes R, Riello AP, Dominici M, Gadelha MR (2008) Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging. Eur J Endocrinol 158(4):459-465
24. Kales A, Bixler EO, Cadieux RJ, Schneck DW, Shaw LC 3rd, Locke TW, Vela-Bueno A, Soldatos CR (1984) Sleep apnoea in a hypertensive population. Lancet 2(8410):1005-1008
25. Fletcher EC (1995) The relationship between systemic hypertension and obstructive sleep apnea: facts and theory. Am J Med 98(2):118-128
26. Assoumou HG, Gaspoz JM, Sforza E, Pichot V, Celle S, Maudoux D, Kossovsky M, Chouchou F, Barthelemy JC, Roche F (2011) Obstructive sleep apnea and the metabolic syndrome in an elderly healthy population: the SYNAPSE cohort. Sleep Breath. doi: 10.1007/s11325-011-0593-y
27. Einhorn D, Stewart DA, Erman MK, Gordon N, Philis-Tsimikas A, Casal E (2007) Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr Pract 13(4):355-362
28. Baldelli R, Battista C, Leonetti F, Ghiggi MR, Ribaudo MC, Paoloni A, D'Amico E, Ferretti E, Baratta R, Liuzzi A, Trischitta V, Tamburrano G (2003) Glucose homeostasis in acromegaly: effects of long-acting somatostatin analogues treatment. Clin Endocrinol (Oxf) 59(4):492-499
29. Steffin B, Gutt B, Bidlingmaier M, Dieterle C, Oltmann F, Schopohl J (2006) Effects of the long-acting somatostatin analogue Lanreotide Autogel on glucose tolerance and insulin resistance in acromegaly. Eur J Endocrinol 155(1):73-78
30. Barbe F, Duran-Cantolla J, Capote F, de la Pena M, Chiner E, Masa JF, Gonzalez M, Marin JM, Garcia-Rio F, de Atauri JD, Teran J, Mayos M, Monasterio C, del Campo F, Gomez S, de la Torre MS, Martinez M, Montserrat JM (2010) Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 181(7):718-726
31. Hassaballa HA, Tulaimat A, Herdegen JJ, Mokhlesi B (2005) The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. Sleep Breath 9(4):176-180